id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-D-0461-0015,FDA,FDA-2009-D-0461,See FDA-2009-D-0461-0026,Supporting & Related Material,,2009-12-30T00:00:00Z,2009,12,,,2013-07-29T17:10:22Z,,0,1,0900006480a70e27
FDA-2009-D-0461-0002,FDA,FDA-2009-D-0461,"Guidance for Industry Format and Content of Proposed Risk Evaluation and Mitigation Strategies (REMS), REMS Assessments, and Proposed REMS Modifications",Other,GDL-Guidance (Supporting and Related Materials),2009-10-01T04:00:00Z,2009,10,2009-10-01T04:00:00Z,2009-12-31T04:59:59Z,2009-10-01T18:24:50Z,,0,0,0900006480a35aeb
FDA-2009-D-0461-0001,FDA,FDA-2009-D-0461,"Draft Guidance for Industry: Format and Content of Proposed Risk Evaluation and Mitigation Strategies, REMS Assessments, and Proposed REMS Modifications",Notice,NAD-Notice of Availability of Data,2009-10-01T04:00:00Z,2009,10,2009-10-01T04:00:00Z,2009-12-31T04:59:59Z,2009-10-01T17:52:42Z,E9-23616,0,0,0900006480a34d5a